Determinants of intramyocellular lipid accumulation in early childhood.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
05 2020
Historique:
received: 26 12 2018
accepted: 30 06 2019
revised: 22 06 2019
pubmed: 30 8 2019
medline: 7 9 2021
entrez: 30 8 2019
Statut: ppublish

Résumé

Accumulation of lipid droplets inside skeletal muscle fibers (intramyocellular lipids or IMCL) with increasing obesity has been linked to skeletal muscle insulin resistance and risk of type 2 diabetes in both adults and prepubertal children. We aimed to evaluate the associations of race, genotype, prenatal factors, and postnatal factors with IMCL in early childhood. This study was a secondary analysis performed on the GUSTO birth cohort. Soleus muscle IMCL of 392 children at 4.5 years of age was measured by magnetic resonance spectroscopy, of which usable imaging data were obtained from 277 children (137 Chinese, 87 Malays, and 53 Indians). Metabolic assessments (fasting glucose, insulin, and HOMA-IR) were performed at age 6. The mean IMCL level at 4.5 years was 0.481 ± 0.279% of water resonance (mean ± sd). Corroborating with results from adults, Indian children had the highest IMCL levels compared with Malay and Chinese children. Among the prenatal factors, the rate of gestational weight gain (GWG rate) was associated with offspring IMCL (B = 0.396 (0.069, 0.724); p = 0.018). Both race and GWG rate continued to be associated with offspring IMCL even after accounting for current offspring BMI. Postnatally, IMCL was associated with shorter breastfeeding duration (B = 0.065 (0.001, 0.128); p = 0.045) and conditional relative weight gain between ages 2 and 3 (B = 0.052 (0.012, 0.093); p = 0.012). The associations with postnatal factors were attenuated after adjusting for current offspring BMI. IMCL was positively associated with offspring BMI (B = 0.028 (0.012, 0.044); p = 0.001). IMCL levels were not associated with fasting glucose, fasting insulin, and HOMA-IR at age 6. This study provides evidence that IMCL accumulation occurs in early childhood and that developmental factors and race are associated with it. We also show that early childhood IMCL accumulation is well tolerated, suggesting that the adverse associations between IMCL and insulin resistance may emerge at older ages.

Sections du résumé

BACKGROUND/OBJECTIVES
Accumulation of lipid droplets inside skeletal muscle fibers (intramyocellular lipids or IMCL) with increasing obesity has been linked to skeletal muscle insulin resistance and risk of type 2 diabetes in both adults and prepubertal children. We aimed to evaluate the associations of race, genotype, prenatal factors, and postnatal factors with IMCL in early childhood.
SUBJECTS/METHODS
This study was a secondary analysis performed on the GUSTO birth cohort. Soleus muscle IMCL of 392 children at 4.5 years of age was measured by magnetic resonance spectroscopy, of which usable imaging data were obtained from 277 children (137 Chinese, 87 Malays, and 53 Indians). Metabolic assessments (fasting glucose, insulin, and HOMA-IR) were performed at age 6.
RESULTS
The mean IMCL level at 4.5 years was 0.481 ± 0.279% of water resonance (mean ± sd). Corroborating with results from adults, Indian children had the highest IMCL levels compared with Malay and Chinese children. Among the prenatal factors, the rate of gestational weight gain (GWG rate) was associated with offspring IMCL (B = 0.396 (0.069, 0.724); p = 0.018). Both race and GWG rate continued to be associated with offspring IMCL even after accounting for current offspring BMI. Postnatally, IMCL was associated with shorter breastfeeding duration (B = 0.065 (0.001, 0.128); p = 0.045) and conditional relative weight gain between ages 2 and 3 (B = 0.052 (0.012, 0.093); p = 0.012). The associations with postnatal factors were attenuated after adjusting for current offspring BMI. IMCL was positively associated with offspring BMI (B = 0.028 (0.012, 0.044); p = 0.001). IMCL levels were not associated with fasting glucose, fasting insulin, and HOMA-IR at age 6.
CONCLUSION
This study provides evidence that IMCL accumulation occurs in early childhood and that developmental factors and race are associated with it. We also show that early childhood IMCL accumulation is well tolerated, suggesting that the adverse associations between IMCL and insulin resistance may emerge at older ages.

Identifiants

pubmed: 31462692
doi: 10.1038/s41366-019-0435-8
pii: 10.1038/s41366-019-0435-8
pmc: PMC7188663
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1141-1151

Subventions

Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/17/31749
Pays : United Kingdom
Organisme : Department of Health
ID : NF-SI-0515-10042
Pays : United Kingdom

Références

Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Farhan S, et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes. 2003;52:244–51.
doi: 10.2337/diabetes.52.2.244
Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma Y-Z, et al. Assessment of skeletal muscle triglyceride content by 1H nuclear magnetic resonance spectroscopy in lean and obese adolescents. Diabetes. 2002;51:1022–7.
doi: 10.2337/diabetes.51.4.1022
Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes. 1999;48:1113–9.
doi: 10.2337/diabetes.48.5.1113
Brumbaugh DE, Crume TL, Nadeau K, Scherzinger A, Dabelea D. Intramyocellular lipid is associated with visceral adiposity, markers of insulin resistance, and cardiovascular risk in prepubertal children: the EPOCH study. J Clin Endocrinol Metab. 2012;97:E1099–105.
doi: 10.1210/jc.2011-3243
De Feyter HM, Schaart G, Hesselink MK, Schrauwen P, Nicolay K, Prompers JJ. Regional variations in intramyocellular lipid concentration correlate with muscle fiber type distribution in rat tibialis anterior muscle. Magn Reson Med. 2006;56:19–25.
doi: 10.1002/mrm.20924
Thamer C, Machann Jr, Bachmann O, Haap M, Dahl D, Wietek B, et al. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab. 2003;88:1785–91.
doi: 10.1210/jc.2002-021674
Høeg L, Roepstorff C, Thiele M, Richter EA, Wojtaszewski JF, Kiens B. Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling. J Appl Physiol. 2009;107:824–31.
doi: 10.1152/japplphysiol.91382.2008
Daemen S, Gemmink A, Brouwers B, Meex RC, Huntjens PR, Schaart G, et al. Distinct lipid droplet characteristics and distribution unmask the apparent contradiction of the athlete’s paradox. Mol Metab. 2018;17:71–81.
doi: 10.1016/j.molmet.2018.08.004
Bennett B, Larson‐Meyer DE, Ravussin E, Volaufova J, Soros A, Cefalu WT, et al. Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children. Obesity. 2012;20:371–5.
doi: 10.1038/oby.2011.264
Weiss R, Taksali SE, Caprio S. Development of type 2 diabetes in children and adolescents. Curr Diabetes Rep. 2006;6:182–7.
doi: 10.1007/s11892-006-0032-9
Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA. 2006;103:18273–7.
doi: 10.1073/pnas.0608537103
Khoo CM, Leow MK-S, Sadananthan SA, Lim R, Venkataraman K, Khoo EYH, et al. Body fat partitioning does not explain the interethnic variation in insulin sensitivity among Asian ethnicity: the Singapore adults metabolism study. Diabetes. 2014;63:1093–102.
doi: 10.2337/db13-1483
Unnikrishnan R, Anjana RM, Mohan V. Diabetes in South Asians: is the phenotype different? Diabetes. 2014;63:53–5.
doi: 10.2337/db13-1592
Soh S-E, Tint MT, Gluckman PD, Godfrey KM, Rifkin-Graboi A, Chan YH, et al. Cohort profile: growing up in Singapore Towards healthy Outcomes (GUSTO) birth cohort study. Int J Epidemiol. 2014;43:1401–9.
doi: 10.1093/ije/dyt125
Cheung YB. Statistical analysis of human growth and development. Boca Raton, FL: CRC Press; 2013.
Yaktine AL, Rasmussen KM. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009.
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672–9.
doi: 10.1002/mrm.1910300604
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
doi: 10.1007/BF00280883
Adair LS, Fall CH, Osmond C, Stein AD, Martorell R, Ramirez-Zea M, et al. Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies. Lancet. 2013;382:525–34.
doi: 10.1016/S0140-6736(13)60103-8
Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc. 2005;67:301–20.
doi: 10.1111/j.1467-9868.2005.00503.x
Arregui M, Buijsse B, Stefan N, Corella D, Fisher E, Di Giuseppe R, et al. Heterogeneity of the stearoyl-CoA desaturase-1 (SCD1) gene and metabolic risk factors in the EPIC-Potsdam study. PLoS ONE. 2012;7:e48338.
doi: 10.1371/journal.pone.0048338
Rudkowska I, Julien P, Couture P, Lemieux S, Tchernof A, Barbier O, et al. Cardiometabolic risk factors are influenced by stearoyl‐CoA desaturase (SCD)− 1 gene polymorphisms and n‐3 polyunsaturated fatty acid supplementation. Mol Nutr Food Res. 2014;58:1079–86.
doi: 10.1002/mnfr.201300426
Warensjö E, Ingelsson E, Lundmark P, Lannfelt L, Syvänen AC, Vessby B, et al. Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity. 2007;15:1732–40.
doi: 10.1038/oby.2007.206
DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32:S157–63.
doi: 10.2337/dc09-S302
Consitt LA, Bell JA, Houmard JA. Intramuscular lipid metabolism, insulin action, and obesity. IUBMB Life. 2009;61:47–55.
doi: 10.1002/iub.142
Schrauwen‐Hinderling VB, Hesselink MK, Schrauwen P, Kooi ME. Intramyocellular lipid content in human skeletal muscle. Obesity. 2006;14:357–67.
doi: 10.1038/oby.2006.47
Devries MC. Sex‐based differences in endurance exercise muscle metabolism: impact on exercise and nutritional strategies to optimize health and performance in women. Exp Physiol. 2016;101:243–9.
doi: 10.1113/EP085369
Amati F, Dubé JJ, Alvarez-Carnero E, Edreira MM, Chomentowski P, Coen PM, et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance. Diabetes. 2011;60:2588–97.
doi: 10.2337/db10-1221
Rudkowska I, Julien P, Couture P, Lemieux S, Tchernof A, Barbier O, et al. Cardiometabolic risk factors are influenced by S tearoyl‐CoA desaturase (SCD)− 1 gene polymorphisms and n‐3 polyunsaturated fatty acid supplementation. Mol Nutr Food Res. 2014;58:1079–86.
doi: 10.1002/mnfr.201300426
Hulver MW, Berggren JR, Carper MJ, Miyazaki M, Ntambi JM, Hoffman EP, et al. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2005;2:251–61.
doi: 10.1016/j.cmet.2005.09.002
Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes. 2001;50:1612–7.
doi: 10.2337/diabetes.50.7.1612
Campbell PJ, Carlson MG, Hill J, Nurjhan N. Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Am J Physiol. 2006;263:E1063–9.
Dragos SM, Bergeron KF, Desmarais F, Suitor K, Wright DC, Mounier C, et al. Reduced SCD1 activity alters markers of fatty acid reesterification, glyceroneogenesis, and lipolysis in murine white adipose tissue and 3T3-L1 adipocytes. Am J Physiol. 2017;313:C295–304.
doi: 10.1152/ajpcell.00097.2017
Risérus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB, et al. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-γ. Diabetes. 2005;54:1379–84.
doi: 10.2337/diabetes.54.5.1379
Miyazaki Y, Glass L, Triplitt C, Matsuda M, Cusi K, Mahankali A, et al. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in type II diabetic patients. Diabetologia. 2001;44:2210–9.
doi: 10.1007/s001250100031
Bódis K, Kahl S, Simon M-C, Zhou Z, Sell H, Knebel B. Reduced expression of stearoyl-CoA desaturase-1, but not free fatty acid receptor 2 or 4 in subcutaneous adipose tissue of patients with newly diagnosed type 2 diabetes mellitus. Nutr Diabetes. 2018;8:49.
doi: 10.1038/s41387-018-0054-9
Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol. 2007;36:220–5.
doi: 10.1093/ije/dyl245

Auteurs

Navin Michael (N)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.

Varsha Gupta (V)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.

Suresh Anand Sadananthan (SA)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.

Aparna Sampathkumar (A)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.

Li Chen (L)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.

Hong Pan (H)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.

Mya Thway Tint (MT)

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Kuan Jin Lee (KJ)

Singapore Bioimaging Consortium, Agency for Science Technology and Research, Singapore, Singapore.

See Ling Loy (SL)

Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
Duke-NUS Medical School, Singapore, Singapore.

Izzuddin M Aris (IM)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.

Lynette Pei-Chi Shek (LP)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Fabian Kok Peng Yap (FKP)

Department of Paediatrics, KK Women's and Children's Hospital, Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Department of Obstetrics and Gynaecology, KK Women's and Children's Hospital, Singapore, Singapore.

Keith M Godfrey (KM)

MRC Lifecourse Epidemiology Unit & NIHR Southampton Biomedical Research Centre, University of Southampton & University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Melvin K-S Leow (MK)

Duke-NUS Medical School, Singapore, Singapore.
Clinical Nutrition Research Centre, Singapore Institute for Clinical Sciences, Agency for Science Technology and Research and National University Health System, Singapore, Singapore.
Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Singapore.
LKC School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore.

Yung Seng Lee (YS)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Michael S Kramer (MS)

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Departments of Pediatrics and of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada.

Christiani Jeyakumar Henry (CJ)

Clinical Nutrition Research Centre, Singapore Institute for Clinical Sciences, Agency for Science Technology and Research and National University Health System, Singapore, Singapore.
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Marielle Valerie Fortier (MV)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.
Department of Diagnostic and Interventional Imaging, KK Women's and Children's Hospital, Singapore, Singapore.

Yap Seng Chong (Y)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.
Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Peter D Gluckman (PD)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore.
Liggins Institute, University of Auckland, Auckland, New Zealand.

Neerja Karnani (N)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore. neerja_karnani@sics.a-star.edu.sg.

S Sendhil Velan (SS)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore, Singapore. sendhil_velan@sbic.a-star.edu.sg.
Singapore Bioimaging Consortium, Agency for Science Technology and Research, Singapore, Singapore. sendhil_velan@sbic.a-star.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH